- Home
- BMHL vs ATRA Comparison
BMHL vs ATRA Comparison
Compare BMHL & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMHL
- ATRA
- Stock Information
- Founded
- BMHL 2016
- ATRA 2012
- Country
- BMHL Hong Kong
- ATRA United States
- Employees
- BMHL N/A
- ATRA N/A
- Industry
- BMHL
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BMHL
- ATRA Health Care
- Exchange
- BMHL Nasdaq
- ATRA Nasdaq
- Market Cap
- BMHL 96.0M
- ATRA 97.0M
- IPO Year
- BMHL 2025
- ATRA 2014
- Fundamental
- Price
- BMHL $3.50
- ATRA $15.07
- Analyst Decision
- BMHL
- ATRA Strong Buy
- Analyst Count
- BMHL 0
- ATRA 3
- Target Price
- BMHL N/A
- ATRA $21.00
- AVG Volume (30 Days)
- BMHL 5.1K
- ATRA 47.4K
- Earning Date
- BMHL 01-01-0001
- ATRA 11-11-2025
- Dividend Yield
- BMHL N/A
- ATRA N/A
- EPS Growth
- BMHL 9.50
- ATRA N/A
- EPS
- BMHL 0.05
- ATRA 0.56
- Revenue
- BMHL $6,873,097.00
- ATRA $188,667,000.00
- Revenue This Year
- BMHL N/A
- ATRA N/A
- Revenue Next Year
- BMHL N/A
- ATRA N/A
- P/E Ratio
- BMHL $68.51
- ATRA $24.82
- Revenue Growth
- BMHL 66.02
- ATRA 202.41
- 52 Week Low
- BMHL $3.37
- ATRA $5.01
- 52 Week High
- BMHL $4.49
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- BMHL N/A
- ATRA 73.07
- Support Level
- BMHL N/A
- ATRA $13.92
- Resistance Level
- BMHL N/A
- ATRA $14.84
- Average True Range (ATR)
- BMHL 0.00
- ATRA 0.93
- MACD
- BMHL 0.00
- ATRA 0.14
- Stochastic Oscillator
- BMHL 0.00
- ATRA 86.53
About BMHL Bluemount Holdings Limited Class B Ordinary Shares
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).